Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €1.84 EUR
Change Today 0.00 / 0.00%
Volume 19.0K
IKM On Other Exchanges
Symbol
Exchange
Berlin
Continuous
As of 11:39 AM 05/5/15 All times are local (Market data is delayed by at least 15 minutes).

1nkemia iuct group sa (IKM) Snapshot

Open
€1.82
Previous Close
€1.84
Day High
€1.84
Day Low
€1.82
52 Week High
06/10/14 - €2.60
52 Week Low
10/10/14 - €1.40
Market Cap
47.7M
Average Volume 10 Days
7.3K
EPS TTM
€0.04
Shares Outstanding
25.9M
EX-Date
--
P/E TM
48.7x
Dividend
--
Dividend Yield
--
Current Stock Chart for 1NKEMIA IUCT GROUP SA (IKM)

Related News

No related news articles were found.

1nkemia iuct group sa (IKM) Related Businessweek News

No Related Businessweek News Found

1nkemia iuct group sa (IKM) Details

1NKEMIA IUCT GROUP, S.A., a technology company, is engaged in the generation, development, promotion, and sale of products and services to the chemical, pharmaceutical, biopharmaceutical, biotechnology, life science, and allied industries. It undertakes research, development, and innovation projects, including development of proprietary R+D and knowledge transfer to industry, contract research, and development of proprietary technology platforms to build strategic cooperative industrial projects. The company also provides technological services, including analytical services, consultancy services, and technical audit, as well as services in the areas of pharmaceutical, nutraceutical, and cosmetic production; knowledge transfer, and scientific and technical training services; and Knowledge Capital Fund that invests in biotechnology companies in early stages of growth. In addition, it focuses on the development of synthesis routes based on the use of various enzymes to improve the production of drugs, apart from nucleoside analogues; and is engaged in the production of organic active ingredients and recombinant proteins for use in cosmetics and para-pharmacy sectors. The company is based in Barcelona, Spain.

1nkemia iuct group sa (IKM) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

1nkemia iuct group sa (IKM) Key Developments

1nKemia IUCT Group, S.A. Presents at BIO-Europe Spring 2015, Mar-09-2015

1nKemia IUCT Group, S.A. Presents at BIO-Europe Spring 2015, Mar-09-2015 . Venue: Paris Expo - Porte de Versailles, Hall 5, Paris, France.

1nKemia IUCT Group, S.A. Presents at 10th Foro MedCap, May-27-2014

1nKemia IUCT Group, S.A. Presents at 10th Foro MedCap, May-27-2014 . Venue: Palacio de la Bolsa, Plaza de la Lealtad, 1, 28014 Madrid, Spain.

Inkemia Opens Brazilian Subsidiary 'Inkemia IUCT Group Tecnologia'

Inkemia has announced the launch of its Brazilian subsidiary. The subsidiary, which is named Inkemia IUCT Group Tecnologia, will begin activities immediately from its Sao Paulo base. Inkemia first announced its intention to open a Brazilian subsidiary in December 2013. The Brazilian government is likely to be amenable to the opening of a local subsidiary by the biotech, as encouraging R&D investment in the country to facilitate technological advancements to stay internationally competitive remains high on the political agenda.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
IKM:SM €1.84 EUR 0.00

IKM Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for IKM.
View Industry Companies
 

Industry Analysis

IKM

Industry Average

Valuation IKM Industry Range
Price/Earnings 43.7x
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow 19.1x
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact 1NKEMIA IUCT GROUP SA, please visit www.inkemia.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.